External Oblique Intercostal Plane Block for Patients Undergoing Upper Abdominal Surgeries

NCT06514417 | Completed

• 1 other identifier: 7/2023ANET12
• Study Type: interventional
• Target: 25
• Locations: 1 country
• Sites: 1

Brief Summary

Ithe study will evaluate the analgesic efficacy of external oblique intercostal block for patients undergoing upper abdominal surgeries

Conditions

Post Operative Pain

Outcome Measures

Primary Outcomes (1)

• Visual analogue pain scale .

  postoperative pain that evaluated by visual analogue pain scale(a scale from 0 to 10 where 0 is interpreted as no pain, 1-4 mild pain, 5-6 moderate pain, 7-10 severe pain)

  24 hours

Secondary Outcomes (1)

• total perioperative analgesics requirements

  24 hours

Study Arms (2)

external oblique intercostal block

ACTIVE COMPARATOR

receive US-guided external oblique intercostal block after induction

Other: US-guided external oblique intercostal block

No block

NO INTERVENTION

receive postoperative morphine on patient request

Interventions

US-guided external oblique intercostal block OTHER

After induction of general anesthesia, external oblique intercostal block will be performed (8) under ultrasonographic guidance with transportable ultrasound device ( Sonosite ,superficial probe ,14-15 MHz). the patient will be positioned supine, and a linear ultrasound transducer will be placed in the sagittal plane between the midclavicular and anterior axillary lines at the level of sixth rib. 20 ml of bupivacaine 0.25% will be injected between the plane of the external oblique and the intercostal muscles. The drug will be injected after a negative aspiration. The contralateral side block will be performed in a same manner.

external oblique intercostal block

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Selected patients will be more than 21 years old with ASA physical status I \& II scheduled for upper abdominal surgeries

You may not qualify if:

• Uncooperative patients.
• Patients who have allergy to any of the used drugs.
• Patients who are on opioids.
• Known abuse of alcohol or medication.
• Local infection at the site of injection or systemic infection.
• Pregnancy
• Patients with coagulation disorders or on anticoagulation therapy

Sponsors & Collaborators

• Menoufia University: lead
• Ayman Ahmed Rady: collaborator
• Ahmed Mohamed Helwa: collaborator

Study Sites (1)

Menoufia university

Cairo, Shibin Elkom, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: lecturer of anaethesia

Study Record Dates

• First Submitted: July 17, 2024
• First Posted: July 23, 2024
• Study Start: July 10, 2023
• Primary Completion: May 10, 2024
• Study Completion: June 10, 2024
• Last Updated: July 24, 2024

Record last verified: 2024-07

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)